Kundrát Pavel, Friedland Werner
Institute of Radiation Protection, Department of Radiation Sciences, Helmholtz Zentrum München, Neuherberg, Germany.
Radiat Prot Dosimetry. 2019 May 1;183(1-2):223-227. doi: 10.1093/rpd/ncy225.
Oncogenic transformed cells represent an in vitro system mimicking early-stage carcinogenesis. These precancerous cells are subject to a selective removal via apoptosis induced by neighbor cells. By modulating the underpinning intercellular signaling mediated by cytokines and reactive oxygen/nitrogen species, ionizing radiation enhances this removal of precancerous cells in vitro, at doses from a few mGy to a few Gy. However, epidemiological data demonstrate that radiation exposure induces cancer, at least above 100 mGy. Mechanistic modeling of the given anti-carcinogenic process explains this discrepancy: The model reproduces in vitro data on apoptosis and its enhancement by radiation. For in vivo-like conditions with signal lifetimes shorter and cell densities higher than in vitro, radiation is predicted to reduce this anti-carcinogenic mechanism. Early-stage lesions that would be turned dormant or completely removed may grow large and escape this control mechanism upon irradiation.
致癌转化细胞代表了一种模拟早期致癌过程的体外系统。这些癌前细胞会通过相邻细胞诱导的凋亡被选择性清除。通过调节由细胞因子和活性氧/氮物种介导的细胞间信号传导,电离辐射在体外以几毫戈瑞到几戈瑞的剂量增强了对癌前细胞的清除。然而,流行病学数据表明,辐射暴露会诱发癌症,至少在100毫戈瑞以上。对给定的抗癌过程进行的机制建模解释了这种差异:该模型再现了体外关于凋亡及其被辐射增强的数据。对于信号寿命比体外短且细胞密度比体外高的类似体内的条件,预计辐射会降低这种抗癌机制。原本会进入休眠或被完全清除的早期病变可能会在辐射后变大并逃脱这种控制机制。